Ghrelin receptor (GHSR-1a)

GHSR-1a (Growth Hormone Secretagogue Receptor 1a) is the canonical signaling receptor for ghrelin, an acylated 28-amino-acid peptide hormone produced primarily by gastric X/A-like cells. As a class A GPCR coupling to Gq/11 and Gi, GHSR-1a mediates ghrelin's dual role as a potent GH secretagogue and a key regulator of appetite, energy homeostasis, and reward-related behavior.

Why it matters in peptide research

GHSR-1a sits at the intersection of two heavily researched domains: the somatotropic axis (GH/IGF-1) and metabolic regulation. At the pituitary level, receptor activation mobilizes intracellular calcium stores and activates protein kinase C, triggering the exocytosis of stored GH granules. This mechanism is complementary to — and synergistic with — GHRH-receptor signaling, which acts through cAMP/PKA. The two pathways together produce GH pulses substantially larger than either can generate independently.

Beyond the pituitary, GHSR-1a is expressed in the hypothalamus (driving appetite and energy sensing), the hippocampus (modulating memory and stress responses), and the heart and vasculature (cardioprotective effects). This broad expression profile means synthetic GHSR-1a agonists — GH secretagogue peptides — have pleiotropic effects that extend well beyond simple GH release.

For peptide researchers, the selectivity of a GHSR-1a agonist is particularly important. Non-selective agonists strongly stimulate appetite and can elevate cortisol and prolactin as off-target effects. Selective agonists aim to maximize GH pulse amplitude while minimizing these ancillary signals, making selectivity a key differentiator when choosing a GHRP-class compound.

Peptides that act on this

• Ipamorelin — highly selective GHSR-1a agonist with minimal effect on cortisol or prolactin; the benchmark for "clean" GH secretagogue activity. Frequently combined with CJC-1295 for maximal GH pulse synergy.
• GHRP-6 — potent but less selective; notable appetite stimulation via hypothalamic GHSR-1a.
• GHRP-2 — intermediate selectivity; stronger GH release than ipamorelin but with more cortisol and prolactin elevation.
• Hexarelin — most potent GHRP; significant desensitization with repeated use.

Common misconceptions

GHSR-1a is sometimes described as a pure "GH release" receptor, which understates its systemic role. Because the receptor exhibits high constitutive activity even in the absence of ghrelin, it sets a tonic baseline for hunger and GH secretion. Antagonizing GHSR-1a reduces appetite — which is why receptor blockers are explored as anti-obesity agents — while activation increases it. Researchers running extended protocols should account for appetite changes and potential alterations in body composition independent of GH release.